A Phase 1 Study of PVT401 in Healthy Subjects

NCT07423000 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Bowel Disease (IBD)

Interventions

DRUG: PVT401
DRUG: Normal Saline (0.9% NaCl)

Sponsor

Parvus Therapeutics, Inc.

Collaborators

[object Object]